Simplify Logo

Internship

Co-Op – Discovery Immunology

Fall 2025

Confirmed live in the last 24 hours

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Princeton, NJ, USA

Role may require at least 50% onsite presence in Princeton, NJ.

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Requirements
  • Completed 2+ years of a relevant life science undergraduate degree or be enrolled in a relevant Master’s degree program.
  • Prior relevant research experience required, preferably in mammalian tissue culture. Must be willing to work with human and mouse primary tissues.
  • A general practical or theoretical understanding of immunology is preferred.
  • Possess a high level of critical thinking, independence, a strong desire to learn new techniques, and the ability to work in a highly dynamic research organization.
  • Able to commit to continuous full-time employment from July - December.
  • Excellent oral, written, and presentation skills.
Responsibilities
  • Isolate and culture primary human and mouse immune cell subsets and cell lines.
  • Assess the function and phenotype of immune cells using molecular techniques (Nucleic Acid Isolation, PCR, ELISA, Western Blot, CRISPR/Cas9, and qPCR), in vitro co-culture assays, and multiparameter flow cytometry.
  • Develop cell-based assays for characterization of large and small molecule compounds with relevant biological readouts (multi-color flow cytometry, ELISA, MSD, protein degradation).
  • Investigate novel target biology in primary epithelial and stromal cell populations.
  • Analyze, compile, and present results when necessary to the appropriate forums.
  • Maintain an electronic record of all experiments and resulting data.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs, providing affordable alternatives that maintain the same quality and safety standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while adhering to sustainability and corporate responsibility principles.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.

Help us improve and share your feedback! Did you find this helpful?